References
Virk RK, Theoharis CGA, Prasad A, Chhieng D, Prasad ML (2014) Morphology predicts BRAF V600E mutation in papillary thyroid carcinoma: an interobserver reproducibility study. Virchows Arch 464:435–442
Rossi ED, Martini M, Capodimonti S, Lombardi CP, Pontecorvi A, Vellone VG, Zannoni GF, Larocca LM, Fadda G (2013) BRAF (V600E) mutation analysis on LBC-processed aspiration biopsies predicts bilaterality and nodal involvement in papillary thyroid microcarcinoma. Cancer Cytopathol 121:291–297
Finkelstein A, Levy GH, Hui P, Prasad A, Virk R, Chhieng DC, Carling T, Roman SA, Sosa JA, Udelsman R, Theoharis CG, Prasad M (2012) Papillary thyroid carcinomas with and without BRAF v600E mutations are morphological distinct. Histopathology 60:1052–1059
Hall A, Meyle KD, Lange MK, Klima M, Sanderhoff M, Dahl C, Abildgaard C, Thorup K, Moghimi SM, Jensen PB, Bartek J, Guldberg P, Christensen C (2013) Dysfunctional oxidative phosphorylation makes malignant melanoma cells addicted to glycolysis driven by the V600EBRAF oncogene. Oncotarget 4:584–599
Rossi ED, Martini M, Capodimonti S, Cenci T, Straccia P, Angrisani B, Ricci C, Lanza P, Lombardi CP, Pontecorvi A, Larocca LM, Fadda G (2014) Analysis of immunocytochemistry and molecular BRAF expression in thyroid carcinoma: a cytohistological institutional experience. Cancer Cytopathol. doi:10.1002/cncy.21416
Conflict of interest
None of the authors listed above has a potential conflict of interest. None of the authors received any funding sources for the manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rossi, E.D., Bizzarro, T., Fadda, G. et al. Is morphology alone able to predict BRAF-mutated malignancies on thyroid FNAC?. Virchows Arch 465, 247–248 (2014). https://doi.org/10.1007/s00428-014-1607-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00428-014-1607-5